Immortal Time Bias or Sorafenib Effect in Elderly Patients With HCC?

被引:0
|
作者
Sanoff, Hanna K. [1 ,2 ]
Chang, YunKyung [1 ,3 ]
Lund, Jennifer L. [1 ,4 ]
O'Neil, Bert H. [5 ]
Dusetzina, Stacie B. [1 ,6 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27599 USA
[3] QuintilesIMS, Res Triangle Pk, NC USA
[4] Univ N Carolina, Ctr Pharmacoepidemiol, Dept Epidemiol, Chapel Hill, NC USA
[5] Indiana Univ Sch Med, Div Hematol Oncol, Dept Med, Indianapolis, IN 46202 USA
[6] Univ N Carolina, Div Pharmaceut Outcomes & Policy, Eshelman Sch Pharm, Chapel Hill, NC USA
关键词
D O I
10.1002/hep.29250
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:678 / 679
页数:2
相关论文
共 50 条
  • [41] Attention to Immortal Time Bias in Critical Care Research
    Vail, Emily A.
    Gershengorn, Hayley B.
    Wunsch, Hannah
    Walkey, Allan J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (10) : 1222 - 1229
  • [42] Immortal Time Bias Can Occur in the Analysis of Dose-Dependent Effect of Statin
    Lin, Chun-Yu
    CHEST, 2018, 153 (06) : 1508 - 1509
  • [43] Sequential Therapy and Immortal Time Bias in Register Studies
    Ambring, A.
    Stierner, U.
    Oden, A.
    Bjorholt, I.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S164 - S164
  • [44] Understanding immortal time bias in observational cohort studies
    Ho, A. M. -H.
    Dion, P. W.
    Ng, C. S. H.
    Karmakar, M. K.
    ANAESTHESIA, 2013, 68 (02) : 126 - 130
  • [45] Response to letter, ‘Immortal time bias in retrospective analysis’
    M A Dimopoulos
    A S Swern
    J S Li
    M Hussein
    L Weiss
    Y Nagarwala
    R Baz
    Blood Cancer Journal, 2015, 5 : e327 - e327
  • [46] Possible Immortal Time Bias in Study of Antibiotic Treatment and Outcomes in Patients Hospitalized for Asthma
    Newman, Thomas B.
    JAMA INTERNAL MEDICINE, 2021, 181 (04) : 568 - 569
  • [47] Immortal time bias in observational studies of drug effects
    Suissa, Samy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (03) : 241 - 249
  • [49] The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)
    Wong, Hilda
    Tang, Yuen Fong
    Yao, Tzy-Jyun
    Chiu, Joanne
    Leung, Roland
    Chan, Pierre
    Cheung, Tan To
    Chan, Albert C.
    Pang, Roberta W.
    Poon, Ronnie
    Fan, Sheung-Tat
    Yau, Thomas
    ONCOLOGIST, 2011, 16 (12): : 1721 - 1728
  • [50] Immortal time bias in observational studies of time-to-event outcomes
    Jones, Mark
    Fowler, Robert
    JOURNAL OF CRITICAL CARE, 2016, 36 : 195 - 199